Articles From: Asta Funding, Inc. Receives Letter From Nasdaq Relating to Its Late Report on Form 10-K to AstraZeneca, oil shares contribute to FTSE 100's advance


2015/1/9
ENGLEWOOD CLIFFS, N.J., Jan.
Sign-up for Asta Funding, Inc. Receives Letter From Nasdaq Relating to Its Late Report on Form 10-K investment picks
2015/2/13
ENGLEWOOD CLIFFS, N.J., Feb.
Sign-up for Asta Funding, Inc. Receives Letter From Nasdaq Relating to Its Late Report on Form 10-Q investment picks
2014/12/30
Evaluation based on Completeness of Vision and Ability to Execute HORSHAM, Pa.
Sign-up for Astea International is Positioned in the Visionaries Quadrant in Gartner's 2014 Magic Quadrant for Field Service Management investment picks
2015/2/17
HORSHAM, Pa.
Sign-up for Astea International to Move to OTCQB Marketplace investment picks
2014/12/16
HORSHAM, Pa.
Sign-up for Astea Receives Positive NASDAQ Listing Determination investment picks
2015/2/19
Astea Alliance Version 12.0 includes scheduling enhancements, additional visualization and collaboration tools, optimized navigation, as well as numerous customer-driven features from around the globe HORSHAM, Pa.
Sign-up for Astea Unveils the Latest Release of its Industry Leading Service Management and Mobile Workforce Solution Suite investment picks
2015/2/24
CHATTANOOGA, Tenn., Feb.
Sign-up for Astec Industries Reports Fourth Quarter and 2014 Results investment picks
2015/2/17
CHATTANOOGA, Tenn., Feb.
Sign-up for Astec Industries, Inc. Announces Its Fourth Quarter and 2014 Conference Call February 24, 2015 at 10:00 A.M. Eastern Time investment picks
2015/2/4
MENLO PARK, Calif.
Sign-up for Asterias Biotherapeutics Announces Public Offering of Common Stock investment picks
2015/2/10
MENLO PARK, Calif.
Sign-up for Asterias Biotherapeutics Completes Public Offering and Private Placement of Common Stock investment picks
2015/2/5
MENLO PARK, Calif.
Sign-up for Asterias Biotherapeutics Prices Public Offering of Common Stock investment picks
2015/1/7
MENLO PARK, Calif.
Sign-up for Asterias Biotherapeutics to Present at Biotech Showcase™ 2015 investment picks
2015/2/18
Aston Hill Capital Markets Inc. Declares Distributions Canada NewsWire TORONTO , Feb.
Sign-up for Aston Hill Capital Markets Inc. Declares Distributions investment picks
2015/2/3
Aston Hill Financial Announces Quarterly Cash Dividend Canada NewsWire CALGARY , Feb.
Sign-up for Aston Hill Financial Announces Quarterly Cash Dividend investment picks
2015/1/7
Managed by Current Aston Subadviser Fairpointe Capital LLC CHICAGO , Jan.
Sign-up for Aston Launches ASTON/Fairpointe Focused Equity Fund investment picks
2015/1/7
Managed by Current Aston Subadviser TAMRO Capital Partners LLC CHICAGO , Jan.
Sign-up for Aston Launches ASTON/TAMRO International Small Cap Fund investment picks
2014/12/1
LAKE SUCCESS, N.Y. , Dec.
Sign-up for Astoria Bank Opens Branch In Melville Today investment picks
2014/12/16
LAKE SUCCESS, N.Y. , Dec.
Sign-up for Astoria Financial Corporation Announces the Passing of Former Chairman, President and Chief Executive Officer, George L. Engelke Jr. investment picks
2015/1/28
Quarterly Cash Dividend of $0.04 Per Common Share Declared LAKE SUCCESS, N.Y. , Jan.
Sign-up for Astoria Financial Corporation Reports Fourth Quarter And Full Year Earnings Per Common Share Of $0.21 And $0.88, Respectively investment picks
2015/1/14
LAKE SUCCESS, N.Y. , Jan.
Sign-up for Astoria Financial Corporation Schedules Fourth Quarter And Full Year Earnings Release & Conference Call investment picks
2015/1/30
LAKE SUCCESS, N.Y., Jan.
Sign-up for Astoria Financial Corporation Sets Annual Meeting Date investment picks
2015/2/24
LAKE SUCCESS, N.Y. , Feb.
Sign-up for Astoria Financial Corporation To Participate In RBC And Deutsche Bank Investor Conferences investment picks
2015/2/18
LAKE SUCCESS, N.Y., Feb.
Sign-up for Astoria Financial Corporation to Participate in the KBW 2015 Boston Regional Bank Conference investment picks
2015/2/2
FRANKFURT--The following is a summary of analysts' forecasts for AstraZeneca plc (AZN) fourth-quarter results, based on a poll of 11 analysts conducted by Dow Jones Newswires (figures in million dollars, EPS and dividend in dollar, target price in pence, according to IFRS). Earnings figures are scheduled to be released February 5.
Sign-up for AstraZeneca plc 4Q 2014 -- Forecast investment picks
2015/2/5
By Marta Falconi AstraZeneca PLC on Thursday reported a fourth-quarter loss, even as a launch of a rival's copy of one of its best-selling drugs, heartburn pill Nexium, was delayed.
Sign-up for AstraZeneca Posts Loss as Sales Fall investment picks
2015/2/5
By Marta Falconi AstraZeneca PLC on Thursday moved to further bulk up its respiratory drug business with the acquisition of Actavis PLC's branded respiratory drug business in the U.S. and Canada for an initial $600 million.
Sign-up for AstraZeneca to Buy Actavis's Respiratory Drug Business in U.S., Canada -- 2nd Update investment picks
2015/2/5
By Marta Falconi AstraZeneca PLC said on Thursday it is acquiring Actavis's branded respiratory drug business in the U.S. and Canada for an initial $600 million as the company reported disappointing fourth-quarter earnings.
Sign-up for AstraZeneca to Buy Actavis's Respiratory Drug Business in U.S., Canada -- Update investment picks
2015/1/29
AstraZeneca (NYSE: AZN) and The University of Texas MD Anderson Cancer Center today announced a multi-year, strategic research collaboration to conduct multiple, parallel clinical and clinically-related studies in ovarian and other gynecologic cancers with the aim of improving patient outcomes.
Sign-up for AstraZeneca, MD Anderson Enter Collaboration to Help Improve Patient Outcomes in Ovarian/ Gynecologic Cancers investment picks
2014/12/18
By Carla Mozee, MarketWatch LONDON (MarketWatch) -- U.K. stocks rose Thursday, in broad-based gains that included a higher move for AstraZeneca following regulatory approval of a drug to treat cancer.
Sign-up for AstraZeneca, oil shares contribute to FTSE 100's advance investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Asta Funding, Inc. Receives Letter From Nasdaq Relating to Its Late Report on Form 10-K to AstraZeneca, oil shares contribute to FTSE 100's advance
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent